|
GRIP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.070400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.256800E-01 |
| Normal-vs-Stage2 |
8.341200E-01 |
| Normal-vs-Stage3 |
6.866000E-01 |
| Normal-vs-Stage4 |
3.686800E-01 |
| Stage1-vs-Stage2 |
7.542800E-01 |
| Stage1-vs-Stage3 |
8.263800E-01 |
| Stage1-vs-Stage4 |
1.944820E-01 |
| Stage2-vs-Stage3 |
6.042000E-01 |
| Stage2-vs-Stage4 |
5.444200E-01 |
| Stage3-vs-Stage4 |
3.072000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.584200E-01 |
| Normal-vs-AfricanAmerican |
6.482200E-01 |
| Normal-vs-Asian |
7.309200E-01 |
| Caucasian-vs-AfricanAmerican |
1.835440E-01 |
| Caucasian-vs-Asian |
6.724200E-01 |
| AfricanAmerican-vs-Asian |
9.042800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.140200E-01 |
| Normal-vs-Female |
4.662300E-02 |
| Male-vs-Female |
7.843100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.212600E-01 |
| Normal-vs-Extreme_Weight |
7.576000E-01 |
| Normal-vs-Obese |
2.452000E-01 |
| Normal-vs-Extreme_Obese |
5.411800E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.244600E-01 |
| Normal_Weight-vs-Obese |
1.097850E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.662400E-01 |
| Extreme_Weight-vs-Obese |
1.423410E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.832800E-01 |
| Obese-vs-Extreme_Obese |
2.684000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.061800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.025400E-01 |
| Normal-vs-Age(61-80Yrs) |
8.073800E-01 |
| Normal-vs-Age(81-100Yrs) |
5.713200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.390000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.629160E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.717990E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.977600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.419400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.379000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.853800E-01 |
| Normal-VS-Type2 PRCC |
4.968800E-01 |
| Normal-VS-KIRP CIMP |
3.224000E-01 |
| Normal-VS-Unclassified PRCC |
8.939000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.777900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
6.229800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.701000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.298400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.696000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.389400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.281560E-01 |
| Normal-vs-N1 |
3.434800E-01 |
| Normal-vs-N2 |
2.102400E-01 |
| N0-vs-N1 |
2.277600E-02 |
| N0-vs-N2 |
5.668000E-01 |
| N1-vs-N2 |
7.602300E-03 |
|
|
